USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Deseret Research Company Inc
Address:
520wakara Way
Salt Lake City, UT 84108
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $187,345.00 4
SBIR Phase II $709,000.00 2

Award List:

EVALUATION OF A RETROVENOUS MYOCARDIAL PERFUSION SYSTEM

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$43,235.00
Agency:
HHS
Principal Investigator:
Jeffrey L. Peters
Abstract:
N/a

CHRONIC PROGRESSIVE HEART FAILURE WILL BE PRODUCED IN SHEEP BY ADMINISTRATION OF SPECIFIC MYOCARDIOTOXIC DRUGS.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
L. steven beck , PRINCIPAL INVESTIGATOR
Abstract:
Chronic progressive heart failure will be produced in sheep by administration of specific myocardiotoxic drugs. in phase i, project feasibility will be determined by administering allylamine, doxorubricin, or cobalt chloride in varying doses to healthy sheep, then following changes which occur with… More

MULTIMONITOR ENDOTRACHEAL TUBE

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$47,110.00
Agency:
HHS
Principal Investigator:
Jeffrey L. Peters , Principal Investigator
Abstract:
N/a

EVALUATION OF A RETROVENOUS MYOCARDIAL PERFUSION SYSTEM

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$382,000.00
Agency:
HHS
Principal Investigator:
Jeffrey L. Peters
Abstract:
Retrovenous diastolic myocardial perfusion (rvdp) with oxygenated blood via the coronary sinus and coronary veins has been shown experimentally to provide 45% of the normal coronary blood flow. rvdp therapy could significantly alter the morbidity of patients with coronary artery disease and acute… More

MULTIMONITOR ENDOTRACHEAL TUBE

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$327,000.00
Agency:
HHS
Principal Investigator:
Jeffrey L. Peters , Principal Investigator
Abstract:
Multimonitors for ecg, temperature, heart sounds, and breath sounds will be fabricated on endotracheal tubes and bench tested. the capability of monitoring multiple physiologic parameters from a single anatomic site (the trachea) is cost efficient in terms of current practice and will provide better… More

THIS STUDY IS DESIGNED TO DEVELOP AND EVALUATE A METHOD OF REPLACING A HOLLOW VISCUS WITH A PROSTHESIS THAT ALLOWS PRIMARY MUCOSAL HEALING AND INCORPORATION OF THE PROSTHETIC INTO THE HEALING PROCESS.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$47,000.00
Agency:
HHS
Principal Investigator:
Richard e hoffer , PRINCIPAL INVESTIGATOR
Abstract:
This study is designed to develop and evaluate a method of replacing a hollow viscus with a prosthesis that allows primary mucosal healing and incorporation of the prosthetic into the healing process. healing of a full thickness isolated bowel segment to 2 types of a hollow viscus prosthesis will be… More